A total of 42 Mergers & Acquisitions (M&A) deals (pending and completed) were announced in the Healthcare of Canada, in the last twelve months resulting in a total deal value of over $8,239.9 million. In the LTM period, August 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $2,287.0 million, resulting in an average deal value of $326.7 million during that month. On the other hand, the month of August 2021 was the most prolific in terms of deal volume, recording a total of 7 deals, resulting in an average deal value of $326.7 million during that month.
Of the 42 deals, the deal secured between Pfizer Inc and Trillium Therapeutics Inc, was the largest M&A deal in the Canada Healthcare sector, which was valued at $2,260.0 million and was completed on August 23, 2021. The second-largest deal was between GSK plc and Sierra Oncology Inc, while the third-largest deal was between Boston Scientific Corp and Baylis Medical Company Inc. The GSK plc-Sierra Oncology Inc deal and the Boston Scientific Corp-Baylis Medical Company Inc deal were valued at $1,900.0 million and $1,750.0 million, respectively. The fourth-largest deal was between Shoppers Drug Mart Inc-LifeMark Health valued at $662.6 million, whereas the deal between Power Financial Corporation-Great-West Lifeco Inc valued at $451.8 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $7,024.4 million and accounted for nearly 85.25% of the total deals (by value) announced during the last twelve months.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
United States of America
United States of America
Japan
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward